Quality assurance for interventions in clinical trials: Multicenter data monitoring, data management, and analysis
- 1 November 1994
- Vol. 74 (S9) , 2647-2652
- https://doi.org/10.1002/1097-0142(19941101)74:9+<2647::aid-cncr2820741811>3.0.co;2-x
Abstract
Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow-up as well as trial end points direct the selection of appropriate compliance measures. To integrate these data to monitor group performance on a specific protocol, to monitor discipline performance, or to monitor an institution's performance is a formidable task. This is especially true for a group such as the Pediatric Oncology Group, where there are a large number of protocols, many diseases, and widely differing protocol requirements. Quality assurance methods for the Pediatric Oncology Group are discussed.Keywords
This publication has 3 references indexed in Scilit:
- Pediatric cancer in the United States. A preliminary report of a collaborative study of the childrens cancer group and the pediatric oncology groupCancer, 1993
- Progress Against Childhood Cancer: The Pediatric Oncology Group ExperiencePublished by American Academy of Pediatrics (AAP) ,1992
- An automated patient registration and treatment randomization system for multicenter clinical trialsControlled Clinical Trials, 1991